Dolutegravir for Children living with HIV

Dolutegravir for Children living with HIV

Picturing Health have developed a short video explaining how dolutegravir (DTG), using preliminary data from the ODYSSEY trial, has gained approval for use in children. Picturing Health is a non-profit film producer with the aim to improve public health. Click here to...

ODYSSEY to be presented at CROI 2020

Results from the ODYSSEY trial will be presented at this year’s Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, USA. The trial team’s abstract titled “Adequate dolutegravir exposure dosed bid with rifampicin in children 6 to <18 years” has...